Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked down their private portfolios by 0.9% ($ weighted) with an average mark-down of 1.6% (equal weighted).
  • Sentiment up:
  • Sentiment down:
  • In July, 32% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 47% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: May 31st, 2024 Reporting Period

-0.9%

Appreciation/Depreciation of All Reported Holdings1

1.6%

Average Mark-Up/Mark-Down Across All Reported Holdings2
CoreWeave
113.9%
Clio
74.7%
KoBold Metals
71.6%
Klarna
53.6%
Scorpion Therapeutics
50.7%
A24 Films
20%
VAST Data
19%
Honor Tech
18.8%
Astranis
16.8%
Chainalysis
16.3%
Moloco
15.2%
Tempus Labs
14.6%
Altos Labs
13.6%
Bolt
13.5%
Circle
12.6%
Meesho
11.9%
Gusto
11.8%
Skyhawk
11.2%
Genesis Therapeutics
9.2%
X Holdings
8.4%
Rapport Therapeutics
8.2%
Faraday Pharma
8.1%
ServiceTitan
8.1%
Bytedance
7.4%
Jumo
7.3%
Discord
5.5%
Tarana
4.8%
Tory Burch
4.5%
Algolia
3.6%
Tenstorrent
3.6%
Odyssey Therapeutics
3.4%
PsiQuantum
3.4%
Relativity Space
3.3%
SecurityScorecard
3.3%
Kartos Therapeutics
3.1%
Savage X
3.1%
Retym
2.6%
Starling Bank
1.9%
Stripe
1.3%
Verily
1.1%
Dragonfly Therapeutics
1%
Omada Health
1%
Waymo
0.9%
YuLife
0.9%
RefleXion Medical
0.8%
Signifyd
0.7%
Tanium
0.6%
AgomAb Therapeutics
0.5%
Arctic Wolf
0.4%
GOAT
0.3%
FogPharma
0.1%
Locus Robotics
0.1%
Skyryse
0.1%
Treeline Bio
0.1%
Xsight Labs
0.1%
6Sense
0%
Accelerant
0%
Ankyra
0%
Cadre
0%
Canva
0%
Carta
0%
Cart.com
0%
Cellanome
0%
Chime
0%
Cohesity
0%
Cross River
0%
DataRobot
0%
Einride
0%
Envoy
0%
Epirus
0%
Everly Health
0%
Fabletics
0%
Figma
0%
Figure Technologies
0%
Flexport
0%
Generate Bio
0%
Harness
0%
Headspace
0%
Heal
0%
Highspot
0%
Houzz
0%
Intercom
0%
JUUL
0%
Laronde
0%
MadHive
0%
Magic Leap
0%
Menlo Micro
0%
Patreon
0%
Phenom
0%
Quell
0%
Scale AI
0%
Shipbob
0%
SpaceX
0%
Talkdesk
0%
Tekion
0%
VideoAmp
0%
Whoop
0%
Deep Genomics
-0.1%
Socure
-0.1%
Cleerly
-0.2%
SalioGen
-0.2%
Castle Creek
-0.3%
FlixBus
-0.4%
FLEXE
-0.5%
Rad Power
-0.7%
Sila Nano
-0.9%
Evozyne
-1.2%
SiMa ai
-1.4%
Ant Group
-1.5%
HaulHub
-1.6%
Bright Peak
-1.8%
Medical Micro
-1.9%
Druva
-2%
Liquid Death
-2.1%
ABL Space
-2.3%
BETA Technologies
-2.6%
Goop
-2.8%
Alif Semi
-3.3%
Sonoma Bio
-3.6%
Tipalti
-4%
Color Genomics
-4.1%
Databricks
-4.2%
Epic Games
-4.2%
Lime
-4.3%
Nuro
-4.3%
PrognomIQ
-4.3%
LifeMine
-4.4%
Snyk
-4.8%
Fanatics
-5.4%
DNA Script
-6.1%
Asimov
-6.2%
Caris
-6.9%
Lightmatter
-7.1%
Grammarly
-7.3%
Unqork
-7.8%
Insitro
-8%
Checkr
-8.5%
Thriveworks
-8.5%
Pine Labs
-9.2%
Redwood Materials
-10%
Diamond Foundry
-10.9%
Kardium
-11.1%
ThoughtSpot
-11.7%
ElevateBio
-11.8%
Enevate
-11.9%
Dataminr
-12.1%
T-Knife
-12.8%
Blink Health
-12.9%
Inscripta
-13.1%
GupShup
-15.4%
Bombas
-15.9%
Aledade
-16.3%
SambaNova
-16.9%
Conformal Medical
-17%
CelLink
-17.1%
Galvanize
-17.5%
Resilience
-19%
MasterClass
-19.1%
Caidya (dMed)
-19.6%
Asapp
-20.2%
Farmers Business Network
-20.6%
Seismic
-20.8%
Freenome
-22%
Saluda Medical
-23.9%
MNTN
-25.9%
Rapyd
-26%
Rappi
-26.9%
Roofstock
-28.5%
goPuff
-29.8%
Wugen
-32.2%
Element Bio
-33.3%
Celonis
-34.6%
MOD Pizza
-38%
Airtable
-47.2%
AgBiome
-51.4%
Adimab
-65.3%
Bowery
-99.7%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked down their private portfolios by 0.9% ($ weighted) with an average mark-down of 1.6% (equal weighted). The period saw three company advancing for every four companies declining.

CoreWeave experienced the most significant mark-up, followed by Clio, KoBold Metals and Klarna. CloudTech & DevOps, Crypto & Blockchain, and AI & Machine Learning saw the largest mark-ups across sectors.

Bowery experienced the most significant mark-down as funds wrote off their positions. Adimab, AgBiome and Airtable also saw significant mark-downs. Among sectors, AgTech, EdTech, and HealthTech saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
Asapp1+80.00%
Sila Nano1+76.90%
Redwood Materials5+68.90%
Scale AI8+67.60%
Lime1+60.30%
Bolt2+51.30%
Tekion4+50.90%
GupShup1+46.90%
Shipbob2+45.30%
Envoy2+41.40%
Flexport2+39.80%
Intercom1+38.60%
Dataminr2+34.60%
FLEXE1+26.40%
Whoop2+26.10%
Stripe8+22.70%
Liquid Death4+22.00%
Anthropic8+21.30%
Carta2+20.80%
Waymo2+20.50%
Meesho6+19.70%
SpaceX8+17.80%
Epirus1+17.00%
Harness1+9.40%
6Sense5+8.60%
Figma4+6.00%
Canva6+5.90%
Aledade5+5.40%
Moloco2+4.20%
CoreWeave6+0.90%
VAST Data5+0.70%
x.AI8+0.50%
Druva2+0.40%
Airtable5+0.10%
Chainalysis6+0.10%
Einride2+0.00%
Chime7-0.20%
Discord6-1.30%
Cohesity1-1.40%
Gusto7-2.60%
DataRobot1-5.30%
ThoughtSpot2-5.90%
Cross River2-6.00%
Databricks7-8.20%
Klarna7-8.30%
Patreon2-9.60%
Relativity Space6-10.60%
Algolia5-10.70%
Omada Health1-11.90%
Lightmatter1-12.70%
Phenom2-14.30%
ServiceTitan4-14.60%
Circle6-15.20%
Epic Games6-16.50%
Socure4-21.20%
Snyk6-21.40%
Tanium1-23.20%
Freenome2-24.00%
Arctic Wolf7-24.90%
Highspot1-28.60%
Fanatics2-28.90%
VideoAmp2-32.30%
Locus Robotics4-32.40%
Rapyd5-33.60%
SecurityScorecard1-33.60%
Cart.com1-36.70%
Bytedance7-42.30%
MNTN1-43.70%
SambaNova5-50.60%
Checkr1-51.10%
JUUL1-52.30%
Celonis1-54.20%
PsiQuantum5-68.20%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In July, 32% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 47% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, Asapp, Sila Nano, and Redwood Materials had the highest positive variance in reported marks versus ZX Index Values. PsiQuantum, Celonis and JUUL had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
AgBiome.97$0.09$0.17$0.00
Farmers Business Network.81$2.93$19.21$2.17
Adimab.59$6.63$18.87$5.40
Rad Power.38$0.73$1.06$0.44
DNA Script.31$315.18$360.42$90.91

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, AgBiome ($0.00 - $0.17) saw the highest share price variance across funds followed by Farmers Business Network ($2.17 - $19.21) and Adimab ($5.40 - $18.87).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Caris
11
Honor Tech
10
Discord
9
Resilience
8
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
MNTN
5
Airtable
4
Databricks
4
FlixBus, Rappi
4

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Caris saw its first positive reversals in eleven quarters while Honor Tech saw its first positive reversal in ten quarters. Discord saw its first positive reversal in nine quarters. MNTN saw its first negative reversal in five quarters while Airtable, Databricks, FlixBus and Rappi all saw their first negative reversals in four quarters.

Disclaimer

This report is based on data reported by 300+ funds and $53+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right